MIT researchers have created a heat-stable lipid nanoparticle formulation for RNA vaccines, addressing the typical requirement for ultracold storage conditions.
To accelerate the development process and optimize stability, the team used a data-efficient AI method to select excipients for the formulation.
The use of AI allowed researchers to more quickly develop stable RNA vaccine formulations, significantly reducing the experimental workload.